These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25845342)

  • 1. Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.
    Tomita T; Kaneda A; Nakagami T; Kaneko S; Yasui-Furukori N
    Hum Psychopharmacol; 2015 Sep; 30(5):334-40. PubMed ID: 25845342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder.
    Tomita T; Ishioka M; Kaneda A; Sugawara N; Nakagami T; Nakamura K; Yasui-Furukori N
    J Affect Disord; 2014 Aug; 165():109-13. PubMed ID: 24882186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of personality factors on paroxetine response time in patients with major depression.
    Kaneda A; Yasui-Furukori N; Nakagami T; Sato Y; Kaneko S
    J Affect Disord; 2011 Dec; 135(1-3):321-5. PubMed ID: 21784533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An attempt to construct a 7-item short version of the temperament and character inventory to predict the treatment response of patients with depression; a validation study.
    Tomita T; Yasui-Furukori N; Kaneda A; Ishioka M; Sugawara N; Nakagami T; Nakamura K
    BMC Psychiatry; 2016 Aug; 16():290. PubMed ID: 27520460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of personality on the association between paroxetine plasma concentration and response.
    Tomita T; Yasui-Furukori N; Nakagami T; Tsuchimine S; Ishioka M; Kaneda A; Nakamura K
    Neuropsychiatr Dis Treat; 2018; 14():3299-3306. PubMed ID: 30568452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Temperament and Character Inventory to Predict Response to Repetitive Transcranial Magnetic Stimulation for Major Depression.
    Siddiqi SH; Chockalingam R; Cloninger CR; Lenze EJ; Cristancho P
    J Psychiatr Pract; 2016 May; 22(3):193-202. PubMed ID: 27123799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression.
    Andre K; Kampman O; Viikki M; Setälä-Soikkeli E; Illi A; Mononen N; Lehtimäki T; Leinonen E
    Acta Neuropsychiatr; 2018 Jun; 30(3):168-174. PubMed ID: 29310728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personality changes during antidepressant treatment.
    Hruby R; Nosalova G; Ondrejka I; Preiss M
    Psychiatr Danub; 2009 Mar; 21(1):25-32. PubMed ID: 19270618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the state dependency of the Temperament and Character Inventory dimensions in patients with major depression: a methodological contribution.
    Hirano S; Sato T; Narita T; Kusunoki K; Ozaki N; Kimura S; Takahashi T; Sakado K; Uehara T
    J Affect Disord; 2002 May; 69(1-3):31-8. PubMed ID: 12103449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.
    Boz C; Gazioglu S; Altunayoglu V; Hocaoglu C
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):534-42. PubMed ID: 17875033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
    Tome MB; Cloninger CR; Watson JP; Isaac MT
    J Affect Disord; 1997 Jul; 44(2-3):101-9. PubMed ID: 9241570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pharmacological treatment on temperament and character in panic disorder.
    Marchesi C; De Panfilis C; Cantoni A; Giannelli MR; Maggini C
    Psychiatry Res; 2008 Mar; 158(2):147-54. PubMed ID: 18234355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression.
    Andre K; Kampman O; Setälä-Soikkeli E; Viikki M; Poutanen O; Nuolivirta T; Mononen N; Lehtimäki T; Leinonen E; Illi A
    J Neural Transm (Vienna); 2010 Dec; 117(12):1431-4. PubMed ID: 21136126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperament and character inventory (TCI) and depression.
    Hansenne M; Reggers J; Pinto E; Kjiri K; Ajamier A; Ansseau M
    J Psychiatr Res; 1999; 33(1):31-6. PubMed ID: 10094237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking.
    Paavonen V; Luoto K; Lassila A; Leinonen E; Kampman O
    Compr Psychiatry; 2018 Jul; 84():26-31. PubMed ID: 29677572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients.
    Kampman O; Poutanen O; Illi A; Setälä-Soikkeli E; Viikki M; Nuolivirta T; Leinonen E
    Eur Psychiatry; 2012 May; 27(4):245-9. PubMed ID: 20933372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERT and NET polymorphisms, temperament and antidepressant response.
    Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
    Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperament and character influence on depression treatment outcome.
    Balestri M; Porcelli S; Souery D; Kasper S; Dikeos D; Ferentinos P; Papadimitriou GN; Rujescu D; Martinotti G; Di Nicola M; Janiri L; Caletti E; Mandolini GM; Pigoni A; Paoli RA; Lazzaretti M; Brambilla P; Sala M; Abbiati V; Bellani M; Perlini C; Rossetti MG; Piccin S; Bonivento C; Fabbro D; Damante G; Ferrari C; Rossi R; Pedrini L; Benedetti F; Montgomery S; Zohar J; Mendlewicz J; Serretti A
    J Affect Disord; 2019 Jun; 252():464-474. PubMed ID: 31005789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?
    Mazza M; Mazza O; Pomponi M; Di Nicola M; Padua L; Vicini M; Bria P; Mazza S
    Compr Psychiatry; 2009; 50(3):240-4. PubMed ID: 19374968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.